| Effectiveness of antipsychotic drugs in patients with chronic schizophrenia JA Lieberman, TS Stroup, JP McEvoy, MS Swartz, RA Rosenheck, ... New England journal of medicine 353 (12), 1209-1223, 2005 | 7580 | 2005 |
| The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity KH Nuechterlein, MF Green, RS Kern, LE Baade, DM Barch, JD Cohen, ... American Journal of Psychiatry 165 (2), 203-213, 2008 | 2514 | 2008 |
| Persistent cannabis users show neuropsychological decline from childhood to midlife MH Meier, A Caspi, A Ambler, HL Harrington, R Houts, RSE Keefe, ... Proceedings of the National Academy of Sciences 109 (40), E2657-E2664, 2012 | 2004 | 2012 |
| The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery RSE Keefe, TE Goldberg, PD Harvey, JM Gold, MP Poe, L Coughenour Schizophrenia research 68 (2-3), 283-297, 2004 | 1713 | 2004 |
| Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial RSE Keefe, RM Bilder, SM Davis, PD Harvey, BW Palmer, JM Gold, ... Archives of general psychiatry 64 (6), 633-647, 2007 | 1444 | 2007 |
| Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment JP McEvoy, JA Lieberman, TS Stroup, SM Davis, HY Meltzer, ... American Journal of Psychiatry 163 (4), 600-610, 2006 | 1268 | 2006 |
| Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria MF Green, KH Nuechterlein, JM Gold, DM Barch, J Cohen, S Essock, ... Biological psychiatry 56 (5), 301-307, 2004 | 1184 | 2004 |
| The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis RSE Keefe, SG Silva, DO Perkins, JA Lieberman Schizophrenia bulletin 25 (2), 201-222, 1999 | 1046 | 1999 |
| Schizophrenia is a cognitive illness: time for a change in focus RS Kahn, RSE Keefe JAMA psychiatry 70 (10), 1107-1112, 2013 | 976 | 2013 |
| Antipsychotic drug effects on brain morphology in first-episode psychosis JA Lieberman, GD Tollefson, C Charles, R Zipursky, T Sharma, RS Kahn, ... Archives of general psychiatry 62 (4), 361-370, 2005 | 954 | 2005 |
| Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment PD Harvey, RSE Keefe American journal of psychiatry 158 (2), 176-184, 2001 | 920 | 2001 |
| The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization RS Kern, KH Nuechterlein, MF Green, LE Baade, WS Fenton, JM Gold, ... American Journal of Psychiatry 165 (2), 214-220, 2008 | 848 | 2008 |
| Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study A Reichenberg, A Caspi, HL Harrington, R Houts, RSE Keefe, RM Murray, ... American Journal of Psychiatry 167 (2), 160-169, 2010 | 694 | 2010 |
| Barriers to employment for people with schizophrenia R Rosenheck, D Leslie, R Keefe, J McEvoy, M Swartz, D Perkins, ... American Journal of Psychiatry 163 (3), 411-417, 2006 | 671 | 2006 |
| Cognitive impairment in schizophrenia RSE Keefe, PD Harvey Novel antischizophrenia treatments, 11-37, 2012 | 651 | 2012 |
| How Should DSM-V Criteria for Schizophrenia Include Cognitive Impairment? RSE Keefe, WS Fenton Schizophrenia bulletin 33 (4), 912-920, 2007 | 600 | 2007 |
| Baseline neurocognitive deficits in the CATIE schizophrenia trial RSE Keefe, RM Bilder, PD Harvey, SM Davis, BW Palmer, JM Gold, ... Neuropsychopharmacology 31 (9), 2033-2046, 2006 | 595 | 2006 |
| Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic TS Stroup, JA Lieberman, JP McEvoy, MS Swartz, SM Davis, ... American Journal of Psychiatry 163 (4), 611-622, 2006 | 587 | 2006 |
| A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia RW Buchanan, M Davis, D Goff, MF Green, RSE Keefe, AC Leon, ... Schizophrenia bulletin 31 (1), 5-19, 2005 | 575 | 2005 |
| A genome-wide investigation of SNPs and CNVs in schizophrenia AC Need, D Ge, ME Weale, J Maia, S Feng, EL Heinzen, KV Shianna, ... PLoS genetics 5 (2), e1000373, 2009 | 573 | 2009 |
Daniel R. WeinbergerLieber Institute for Brain DevelopmentDirección de correo verificada de libd.org
